Filing Details
- Accession Number:
- 0001127602-24-027248
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-13 17:46:02
- Reporting Period:
- 2024-11-11
- Accepted Time:
- 2024-11-13 17:46:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591313 | R John Desjarlais | C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107 | Sr. Vice President & Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-11 | 68,684 | $15.69 | 268,788 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-11 | 68,684 | $23.48 | 200,104 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-11-12 | 12,774 | $15.69 | 212,878 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-11-11 | 68,684 | $0.00 | 68,684 | $15.69 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-11-12 | 12,774 | $0.00 | 12,774 | $15.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,316 | 2025-02-11 | No | 4 | M | Direct | |
| 3,542 | 2025-02-11 | No | 4 | M | Direct |
Footnotes
- This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 14, 2024.
- Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.25 to $24.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- 25% of the shares subject to the option vested on the one year anniversary of February 12, 2015 (the "Vesting Commencement Date"), and 1/48th of the shares vested monthly thereafter, such that the option was fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
Billionaire Hedge Funds
